GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Accounts Payable & Accrued Expense

Genesystem Co (XKRX:363250) Accounts Payable & Accrued Expense : ₩0.0 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Accounts Payable & Accrued Expense?

Genesystem Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩244.1 Mil) to Dec. 2023 (₩244.0 Mil) and declined from Dec. 2023 (₩244.0 Mil) to Mar. 2024 (₩0.0 Mil).

Genesystem Co's annual accounts payable & accrued expense declined from Dec. 2021 (₩666.1 Mil) to Dec. 2022 (₩318.6 Mil) and declined from Dec. 2022 (₩318.6 Mil) to Dec. 2023 (₩244.0 Mil).


Genesystem Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Genesystem Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Accounts Payable & Accrued Expense Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
179.06 347.44 666.13 318.56 244.05

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 342.37 255.45 244.12 244.05 -

Genesystem Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines